Kate Hammerman is an accomplished veterinary pathologist with extensive experience in both academia and the pharmaceutical industry. They served as a Veterinary Pathologist at Harvard University from 2006 to 2010, specializing in diagnostic and investigative pathology. From 2010 to 2022, they held various roles at Pfizer, culminating as the Drug Safety Team Lead, focusing on toxicologic pathology and clinical trial evaluations. Currently, they are the Vice President and Head of Global Pathology at Pfizer, overseeing all pathology support for GLP and investigative studies. Kate earned a PhD in Cell & Molecular Biology/Infectious Disease from the University of Pennsylvania in 2006.
This person is not in the org chart
This person is not in any teams
This person is not in any offices